Crofelemer: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Crofelemer. Educational only — not medical advice.
Labeled uses
MYTESI is indicated for symptomatic relief of non-infectious diarrhea in adult patients with HIV/AIDS on anti-retroviral therapy.
Source: FDA labeling via NIH DailyMed (set 45584fba…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.